Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCRI Oncology Partners is a leading cancer treatment center based in Nashville, Tennessee, specializing in state-of-the-art personalized cancer care, clinical research, and access to innovative clinical trials. The center is led by globally recognized oncologists and hematologists with disease-specific expertise, and it is affiliated with Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations. SCRI Oncology Partners participates in hundreds of clinical trials across all stages of cancer, focusing on delivering the latest commercially available and investigational therapies to patients in their own community. The center is part of The US Oncology Network, a national organization advancing value-based community oncology care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCRI Oncology Partners.